EX-10.1
from 8-K
49 pages
Senior Secured, Super-Priority Debtor-In-Possession Loan and Security Agreement by and Among Sorrento Therapeutics, Inc. Scintilla Pharmaceuticals, Inc. as Borrowers, and Oramed Pharmaceuticals Inc., as Lender Dated as of August 9, 2023
12/34/56
EX-10.1
from 8-K
58 pages
Senior Secured, Super-Priority Debtor-In-Possession Loan and Security Agreement by and Among Sorrento Therapeutics, Inc. Scintilla Pharmaceuticals, Inc. as Borrowers, and Jmb Capital Partners Lending, LLC, as Lender Dated as of March 30, 2023
12/34/56
EX-10.5
from 10-Q
98 pages
Term Loan Agreement Dated as of November 7, 2018 Among Sorrento Therapeutics, Inc., as Borrower, Certain Subsidiaries of Sorrento Therapeutics, Inc., as Guarantors, Sc Investments Ne Holdings, LLC, Sc Investments E Holdings, LLC, Oaktree Strategic Income II, Inc., and Ocsl SRNE, LLC, as Lenders, and Oaktree Fund Administration, LLC, as Agent $150,000,000 Senior Secured First Lien Term Loan
12/34/56